Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) saw a significant growth in short interest in April. As of April 30th, there was short interest totaling 2,000 shares, a growth of ∞ from the April 15th total of 0 shares. Based on an average daily volume of 75 shares, the short-interest ratio is currently 26.7 days.
Viva Biotech Price Performance
Shares of Viva Biotech stock opened at $0.20 on Monday. The firm has a 50 day simple moving average of $0.33 and a 200 day simple moving average of $0.29. Viva Biotech has a fifty-two week low of $0.13 and a fifty-two week high of $0.43.
Viva Biotech Company Profile
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
Further Reading
- Five stocks we like better than Viva Biotech
- These Stocks Could Be the Biggest Winners of the 2026 Midterms
- 3 Infrastructure Stocks Fueling the Data Center Building Boom
- Datadog Soars, Dynatrace Slumps: Gap Widens in AI Agent Stocks
- As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
